A Clinical Study to Evaluate the Efficacy and Safety of SIM0417 Orally Co-Administered With Ritonavir in Symptomatic Adult Participants With Mild to Moderate COVID-19
Clinical trial NCT05506176 · COMPLETED
Trial details
- NCT number
- NCT05506176
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-19
- Primary completion
- 2023-01-23
- Enrollment
- 1208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.